A detailed history of Adage Capital Partners Gp, L.L.C. transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 312,615 shares of ANTX stock, worth $678,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares
312,615
Previous 900,672 65.29%
Holding current value
$678,374
Previous $18.5 Million 94.5%
% of portfolio
0.0%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.78 - $21.53 $1.63 Million - $12.7 Million
-588,057 Reduced 65.29%
312,615 $1.02 Million
Q4 2023

Feb 14, 2024

SELL
$13.92 - $21.0 $67,985 - $102,564
-4,884 Reduced 0.54%
900,672 $18.5 Million
Q3 2023

Nov 14, 2023

BUY
$7.58 - $16.08 $6.86 Million - $14.6 Million
905,556 New
905,556 $14.6 Million

Others Institutions Holding ANTX

About AN2 Therapeutics, Inc.


  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $42.1M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.